or Try an Advanced Search...

    Technical Analysis for ONCY - Oncolytics Biotech Inc.

    Grade Last Price % Change Price Change
    C 1.15 -1.29% -0.02
    ONCY closed down 1.69 percent on Wednesday, May 15, 2024, on 1.44 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical ONCY trend table...
    Date Alert Name Type % Chg
    New Uptrend Bullish -1.29%
    Earnings Movers Other -1.29%
    Outside Day Range Expansion -1.29%
    Gapped Up Strength -1.29%
    Calm After Storm Range Contraction -2.97%
    Inside Day Range Contraction -2.97%
    Calm After Storm Range Contraction -2.14%
    Inside Day Range Contraction -2.14%
    Bearish Engulfing Bearish -2.14%
    Upper Bollinger Band Walk Strength -2.14%
    Older End-of-Day Signals for ONCY ...

       Recent Intraday Alerts

    Alert Time
    Fell Below 20 DMA about 4 hours ago
    20 DMA Support about 4 hours ago
    60 Minute Opening Range Breakdown about 4 hours ago
    Fell Below Previous Day's Low about 4 hours ago
    Down 2 % about 4 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ONCY Chart by TradingView
    Basic chart:

    Profile

    Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Treatment Of Cancer Pharmaceutical Products Oncolytics Biotech Synbio

    Is ONCY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
    May 15 Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
    May 10 Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript
    May 10 Oncolytics Biotech, Inc. (ONCY) Q1 2024 Earnings Call Transcript
    May 9 Oncolytics Biotech GAAP EPS of -$0.09 misses by $0.01
    May 9 Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights
    May 9 Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer
    May 8 Oncolytics Biotech Q1 2024 Earnings Preview
    May 8 Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
    Apr 30 Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
    See more ONCY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.3942
    52 Week Low 0.883
    Average Volume 235,646
    200-Day Moving Average 1.49
    50-Day Moving Average 1.09
    20-Day Moving Average 1.13
    10-Day Moving Average 1.18
    Average True Range 0.06
    RSI (14) 54.75
    ADX 26.19
    +DI 24.40
    -DI 9.96
    Chandelier Exit (Long, 3 ATRs) 1.09
    Chandelier Exit (Short, 3 ATRs) 1.20
    Upper Bollinger Bands 1.25
    Lower Bollinger Band 1.01
    Percent B (%b) 0.64
    BandWidth 20.90
    MACD Line 0.03
    MACD Signal Line 0.02
    MACD Histogram 0.0023
    Fundamentals Value
    Market Cap 85.14 Million
    Num Shares 73.4 Million
    EPS -0.38
    Price-to-Earnings (P/E) Ratio -3.05
    Price-to-Sales 0.00
    Price-to-Book 3.58
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.30
    Resistance 3 (R3) 1.30 1.27 1.27
    Resistance 2 (R2) 1.27 1.23 1.26 1.26
    Resistance 1 (R1) 1.21 1.21 1.20 1.21 1.26
    Pivot Point 1.18 1.18 1.17 1.17 1.18
    Support 1 (S1) 1.12 1.14 1.11 1.12 1.06
    Support 2 (S2) 1.09 1.12 1.08 1.06
    Support 3 (S3) 1.03 1.09 1.05
    Support 4 (S4) 1.03